Dobutamine-induced hypotension is an independent predictor for mortality in patients with left ventricular dysfunction following myocardial infarction

International Journal of Cardiology

Volumn 68, Issue 3, 1999, Pages 297-302

  Wang, Chao Hung ^a   Cherng, Wen Jin ^a   Hung, Ming Jui ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Dobutamine echocardiography; Hypotension; Myocardial infarction

Indexed keywords

ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADRENERGIC BETA-AGONISTS; AGED; BLOOD PRESSURE; DEATH, SUDDEN, CARDIAC; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPOTENSION; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033559726     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00376-3     Document Type: Article

References (16)

1. Meluzin J., Cigarroa C.G., Brickner E.et al. Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarction. Am J Cardiol. 96:1995;877-880.
2. Afridi I., Kleiman N.S., Raizner A.E., Zoghbi W.A. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 91:1995;663-670.
3. Tanimoto M., Pai R.G., Jintapakom W., Shah P.M. Mechanisms of hypotension during dobutamine stress echocardiography in patients with coronary artery disease. Am J Cardiol. 76:1995;26-30.
4. Geleijnse M.L., Elhendy A., Rambaldi R.et al. Prognostic significance of systolic blood pressure changes during dobutamine-atropine stress Technetium-99m Sestamibi perfusion scintigraphy in patients with chest pain and known or suspected coronary artery disease. Am J Cardiol. 79:1997;1031-1035.
5. Rosamond T.L., Vacek J.L., Hurwitz A., Rowland A.J., Beauchamp G.D., Crouse U. Elypotension during dobutamine stress echocardiography: initial description and clinical relevance. Am Heart J. 123:1992;403-407.
6. Wang C.H., Cherug W.J., Hung M.J. The effect of dobutamine-induced myocardial ischemia on Doppler echocardiography following myocardial infarction. Am Heart J. 134:1997;1058-1065.
7. Colucci W.S., Alexander R.W., Williams G.H.et al. Decreased lymphocyte betaadrenergic-receptor density in patients with heart failure and tolerance to the betaadrenergic agonist pirbuterol. N Engl J Med. 305:1981;185-190.
8. Weiss R.J., Tobes M., Wertz C.E., Smith C.B. Platelet alpfa2 adrenoreceptors in chronic congestive heart failure. Am J Cardiol. 52:1983;101-105.
9. Tsutamoto T., Wada A., Maeda K.et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 96:1997;509-516.
10. Port I.D., Larabee P., Weiderin J.et al. Differences in ventricular myocardial beta receptor expression in ischemic versus idiopathic dilated cardiomyopathy. Circulation. 80(Suppl. IV):1989;8.
11. Fowler M.B., Laser J.A., Hopkins G.L., Minobe W., Bristow M.R. Assessment of the β-adrenergic receptor pathway in the intact failing human heart. Circulation. 74:1986;1290-1302.
12. Ogawa K., Ito T. Pathophysiologic and prognostic considerations in circulatory insufficiency in congestive heart failure: receptor function. Jpn Circ J. 53:1989;123-130.
13. El Said E.S., Roelandt J.R., Fioretti P.M.et al. Abnormal left ventricular early diastolic filling during dobutamine stress Doppler echocardiography is a sensitive indicator of significant coronary artery disease. J Am Coll Cardiol. 24:1994;1618-1624.
14. Heilbrunn S.M., Shah P., Bristow M.R., Valantine H.A., Ginsburg R., Fowler M.B. Inceased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation. 79:1989;483-490.
15. Persson H., Erhardt L. Beta receptor antagonists in the treatment of heart failure. Cardiovasc Drugs Ther. 5:1991;589-604.
16. Guy S., Silke B. Dobutamine stress testing in chronic heart failure dose response effects assessed by echo-Doppler. Postgrad Med J. 67(suppl.):1991;562-568.